PF3D7_0108000 |
PFA0400c |
proteasome subunit beta type-3, putative |
PlasmoDB |
TDR |
|
((R)-2-([1,1'-biphenyl]-4-yl)-1-((S)-2-((R)-1-acetylpyrrolidine-2-carboxamido)propanamido)ethyl)boronic acid |
|
|
PF3D7_0518300 |
PFE0915c |
proteasome subunit beta type-1, putative |
PlasmoDB |
TDR |
|
(S)-2,2-diheptyl-3-(5-(6-methoxyquinolin-8-yl)pentyl)-5-methylimidazolidin-4-one |
|
Bortezomib
|
|
|
PF3D7_0803800 |
MAL8P1.142 |
proteasome subunit beta type-4 |
PlasmoDB |
TDR |
|
|
PF3D7_0931800 |
PFI1545c |
proteasome subunit beta type-6, putative |
PlasmoDB |
TDR |
|
(S)-N1-(2-([1,1'-biphenyl]-4-carboxamido)ethyl)-N4-(tert-butyl)-2-(3-phenylpropanamido)succinamide |
|
|
PF3D7_1011400 |
PF10_0111 |
proteasome subunit beta type-5 |
PlasmoDB |
TDR |
|
|
PF3D7_1327900 |
PF13_0156a |
conserved Plasmodium protein, unknown function |
PlasmoDB |
TDR |
|
|
PF3D7_1470900 |
PF14_0676 |
proteasome subunit beta type-2, putative |
PlasmoDB |
TDR |
|
(S)-2-((S)-2-(1H-indol-3-yl)-2-(2-morpholinoacetamido)acetamido)-4-methyl-N-((S,E)-5-methyl-1-(methylsulfonyl)hex-1-en-3-yl)pentanamide
|
|
(S)-2-((S)-2-(1H-indol-3-yl)-2-(2-morpholinoacetamido)acetamido)-N-((S,E)-1-(1H-indol-3-yl)-4-(methylsulfonyl)but-3-en-2-yl)-4-methylpentanamide |
|
Bortezomib
|
|
dihydroartemisinin
|
|
N-[(3S)-1-[1-[(E,1S)-1-ethyl-3-methylsulfonyl-allyl]-5-methyl-2-oxo-3-piperidyl]-5-methyl-2-oxo-3-piperidyl]-2-morpholino-acetamide;indole |
|
N-[(3S)-5-(1H-indol-3-yl)-1-[1-[(1S)-3-methyl-1-[(E)-2-methylsulfonylvinyl]butyl]-2-oxo-3-piperidyl]-2-oxo-3-piperidyl]-2-morpholino-acetamide |
|
N-[(3S)-5-(1H-indol-3-yl)-1-[1-[(E,1S)-1-(1H-indol-3-ylmethyl)-3-methylsulfonyl-allyl]-5-methyl-2-oxo-3-piperidyl]-2-oxo-3-piperidyl]-2-morpholino-acetamide |
|
N-[(3S)-5-(1H-indol-3-yl)-1-[5-methyl-1-[(1R)-3-methyl-1-[(E)-2-methylsulfonylvinyl]butyl]-2-oxo-3-piperidyl]-2-oxo-3-piperidyl]-2-morpholino-acetamide |
|
N-[(3S)-5-methyl-1-[1-[(1S)-3-methyl-1-[(E)-2-methylsulfonylvinyl]butyl]-2-oxo-3-piperidyl]-2-oxo-3-piperidyl]-2-morpholino-acetamide |
|
|